About this Journal Submit a Manuscript Table of Contents

Human Trypanosomiasis

Call for Papers

Human trypanosomiasis comprises the diseases caused by protozoan parasites belonging to the genus Trypanosom a, such as African trypanosomiasis (sleeping sickness) and American trypanosomiasis (Chagas disease). They are usually classified as tropical infections and can be currently considered as one of the most serious health problems worldwide. The drugs available for the treatment of both diseases have numerous side effects their effectiveness varies according to geographical region and furthermore are not suitable for the advanced stages of the infection. Therefore, there is an urgent need for new drugs more effective and with better pharmacological profiles to cover this vacancy area.

We invite authors to submit original research and review articles related to up-to-date and ongoing research focusing on the development and evaluation of potential anti- Trypanosoma agents. We aim to highlight research covering all stages of investigation, such as in silico studies, synthesis efforts, in vitro studies, and in vivo evaluations.

Potential topics include, but are not limited to:

  • Development and testing of novel and effective anti- Trypanosoma agents
  • Identification and testing of novel natural products with anti- Trypanosoma action
  • Study of the possible mechanisms of action of anti- Trypanosoma agents
  • New therapeutic targets for drug design against trypanosomes
Manuscript DueFriday, 12 September 2014
First Round of ReviewsFriday, 5 December 2014
Publication DateFriday, 30 January 2015

Lead Guest Editor

Guest Editors